NCT02272647View on ClinicalTrials.gov

Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2018

Conditions
Healthy
Interventions
DRUG

IM Saline Placebo (0.25 ml)

DRUG

IM Estradiol valerate (2.5 mg)

DRUG

IM Saline Placebo (0.5 ml)

DRUG

IM Estradiol valerate (5.0 mg)

DRUG

Oral Micronized Progesterone

DRUG

Oral Placebo

DRUG

Ghrelin (0.3 ug/kg)

DRUG

Medroxyprogesterone - Acetate

DRUG

Oral Placebo

(in lieu of Medroxyprogesterone)

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02272647 - Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women | Biotech Hunter | Biotech Hunter